Trial Profile

Phase Ia trial of brilacidin [PMX 30063] in volunteers.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 16 Dec 2008

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Brilacidin (Primary)
Indications Staphylococcal infections
Focus Adverse reactions

Most Recent Events

11 Dec 2008 Status changed from recruiting to completed.
22 Aug 2008 Status changed from initiated to recruiting as reported in a PolyMedix media release.
26 May 2008 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com